Cardiac manifestations of acute carbamate and organophosphate poisoning

A M Saadeh1, N A Farsakh, M K al-Ali

  • 1Princess Basma Teaching Hospital, Faculty of Medicine, Jordan University of Science, Irbid, Jordan.

Insights

Cardiac complications are frequent in organophosphate and carbamate poisoning, with ECG abnormalities common. Prompt intensive care and atropine can reduce mortality from these poisonings.

Area of Science:

  • Toxicology
  • Cardiology
  • Critical Care Medicine

Background:

  • Organophosphate and carbamate poisoning are significant public health concerns.
  • Cardiac complications can arise from these poisonings, impacting patient outcomes.
  • Understanding the frequency and nature of these cardiac issues is crucial for effective management.

Purpose of the Study:

  • To investigate the incidence, extent, and underlying mechanisms of cardiac complications in organophosphate and carbamate poisoning.
  • To identify predisposing factors for cardiac involvement in poisoned patients.

Main Methods:

  • A retrospective study was conducted.
  • Data were collected from 46 adult patients admitted to a medical intensive care unit (MICU) over five years.
  • Patients diagnosed with organophosphate or carbamate poisoning were included.

Main Results:

  • Cardiac complications occurred in 67% of patients, including non-cardiogenic pulmonary edema (43%) and arrhythmias (24%).
  • Electrocardiographic abnormalities were prevalent, with prolonged Q-Tc interval (67%) and ST-T changes (41%) noted.
  • Hypotension (17%) and hypertension (22%) were observed, with 17% requiring respiratory support. In-hospital mortality was 4% due to ventricular fibrillation.

Conclusions:

  • Cardiac complications are common in organophosphate and carbamate poisoning, especially within the initial hours.
  • Hypoxemia, acidosis, and electrolyte imbalances are key predisposing factors.
  • Early and aggressive supportive care, including adequate atropine dosage, in intensive or coronary care settings can decrease mortality.
Abstract

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...